The science behind many antidepressants appears to be backwards, researchers say

February 18, 2015

The science behind many antidepressant medications appears to be backwards, say the authors of a paper that challenges the prevailing ideas about the nature of depression and some of the world's most commonly prescribed medications.

The authors of the paper, posted by the journal Neuroscience & Biobehavioral Reviews, combed existing research for evidence to support the theory that has dominated nearly 50 years of depression research: that depression is related to low levels of in the gaps between cells in the brain.

The low-serotonin theory is the basis for commonly prescribed called selective serotonin re-uptake inhibitors, or SSRIs, which keep the neurotransmitter's levels high by blocking its re-absorption into the cells that release it.

Those serotonin-boosting medications actually make it harder for patients to recover, especially in the short term, says lead author Paul Andrews, an assistant professor of Psychology, Neuroscience & Behaviour at McMaster.

"It's time we rethink what we are doing," Andrews says. "We are taking people who are suffering from the most common forms of depression, and instead of helping them, it appears we are putting an obstacle in their path to recovery."

When depressed patients on SSRI medication do show improvement, it appears that their brains are actually overcoming the effects of antidepressant medications, rather than being assisted directly by them. Instead of helping, the medications appear to be interfering with the brain's own mechanisms of recovery.

"We've seen that people report feeling worse, not better, for their first two weeks on antidepressants," Andrews says. "This could explain why."

It is currently impossible to measure exactly how the brain is releasing and using serotonin, the researchers write, because there is no safe way to measure it in a living human brain. Instead, scientists must rely on measuring evidence about levels of serotonin that the brain has already metabolized, and by extrapolating from studies using animals.

The best available evidence appears to show that there is more serotonin being released and used during depressive episodes, not less, the authors say. The paper suggests that serotonin helps the brain adapt to depression by re-allocating its resources, giving more to conscious thought and less to areas such as growth, development, reproduction, immune function, and the stress response.

Andrews, an evolutionary psychologist, has argued in previous research that antidepressants leave patients in worse shape after they stop using them, and that most forms of , though painful, are natural and beneficial adaptations to stress.

Explore further: Why some antidepressants may initially worsen symptoms

Related Stories

Why some antidepressants may initially worsen symptoms

December 17, 2014
New research helps explain a paradoxical effect of certain antidepressants—that they may actually worsen symptoms before helping patients feel better. The findings, highlighted in a paper publishing online December 17 in ...

Early exposure to antidepressants affects adult anxiety and serotonin transmission

December 19, 2014
About 15 percent of women in the United States suffer from anxiety disorders and depression during their pregnancies, and many are prescribed antidepressants. However little is known about how early exposure to these medications ...

Compound enhances SSRI antidepressant's effects in mice

June 21, 2013
A synthetic compound is able to turn off "secondary" vacuum cleaners in the brain that take up serotonin, resulting in the "happy" chemical being more plentiful, scientists from the School of Medicine at The University of ...

Can a genetic test help predict which antidepressant will be most effective?

December 8, 2014
Depression is the most commonly diagnosed mental illness, and antidepressants are the most frequently prescribed treatments for it. But with dozens of medications to choose from, and with individuals responding better to ...

Serotonin-deficient brains more vulnerable to social stress

February 9, 2015
Mice genetically deficient in serotonin—a crucial brain chemical implicated in clinical depression—are more vulnerable than their normal littermates to social stressors, according to a Duke study appearing this week in ...

New study throws into question long-held belief about depression

August 27, 2014
New evidence puts into doubt the long-standing belief that a deficiency in serotonin—a chemical messenger in the brain—plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that ...

Recommended for you

Anti-stress compound reduces obesity and diabetes

December 13, 2017
For the first time, scientists from the Max Planck Institute of Psychiatry in Munich could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment ...

Encouraging risk-taking in children may reduce the prevalence of childhood anxiety

December 13, 2017
A new international study suggests that parents who employ challenging parent behavioural (CPB) methods – active physical and verbal behaviours that encourage children to push their limits – are likely protecting their ...

Researchers link epigenetic aging to bipolar disorder

December 12, 2017
Bipolar disorder may involve accelerated epigenetic aging, which could explain why persons with the disorder are more likely to have - and die from - age-related diseases, according to researchers from The University of Texas ...

Researchers find common psychological traits in group of Italians aged 90 to 101

December 12, 2017
In remote Italian villages nestled between the Mediterranean Sea and mountains lives a group of several hundred citizens over the age of 90. Researchers at the University of Rome La Sapienza and University of California San ...

Twitter can reveal our shared mood

December 11, 2017
In the largest study of its kind, researchers from the University of Bristol have analysed mood indicators in text from 800 million anonymous messages posted on Twitter. These tweets were found to reflect strong patterns ...

Infant brain responses predict reading speed in secondary school

December 11, 2017
A study conducted at the Department of Psychology at the University of Jyväskylä, Finland and Jyväskylä Centre for Interdisciplinary Brain Research (CIBR) has found that the brain responses of infants with an inherited ...

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

the_mind_show
not rated yet Feb 18, 2015
One of the most novel and effective European anti-depressants has been characterized as a serotonin reuptake ENHANCER. It shouldn't be a surprise to hear that it is not prescribed in English speaking countries.
monkerypiano
5 / 5 (1) Feb 18, 2015
I am psychiatrist who both prescribes antidepressants (and is reluctant to do so because of the side effects), and researcher into the mechanisms of action of antidepressants,all I can say is that ideologues on either side of a debate are always forgotten by history.Anti depressants are likely over and underutilized.The idea that people universally get worse for the first two weeks is as true and clear minded as that god created the sun on the fourth day even though there was sun on the first three.The quality of this mans research merits publication either in the obscure journal it was in, or the enquirer.
RobertKarlStonjek
not rated yet Feb 18, 2015
Andrews, an evolutionary psychologist, has argued in previous research that antidepressants leave patients in worse shape after they stop using them, and that most forms of depression, though painful, are natural and beneficial adaptations to stress.


This is true only for normal transient depression but not for clinical depression which persists despite no obvious cause and no adaptive function.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.